PATENT CLAIM ANALYSIS

Application Number: 16192347
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-09
Patent Classification: ["424", "186100"]

Abstract:
The disclosure provides modified cytomegalovirus (CMV) gL proteins and complexes comprising gL proteins. The modified gL proteins remain intact and are able to form complexes with other CMV proteins.

Claim (Index 20):
The process of  claim 17 , wherein the complex comprises an HCMV gL protein, or complex-forming fragment thereof, having a substitution mutation at a residue corresponding to A96, N97, S98, or a combination thereof, numbered according to SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15544730', '15522455', '14410461', '15596066', '13409987']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8155359053488916
- 35 USC 102 Novelty (BERT): 0.6452786890549059
- Combined Prediction Score: 0.798510183719493
- Mean Citation Score: 505.217634
- Max Citation Score: 663.51495
- Similarity Product: 574.3453759156732

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test